nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Leukopenia—Thiotepa—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Methotrexate—urinary bladder cancer	0.00302	0.00302	CcSEcCtD
Gallamine Triethiodide—Cough—Thiotepa—urinary bladder cancer	0.00296	0.00296	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Thiotepa—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00287	0.00287	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Cisplatin—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Methotrexate—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Epirubicin—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.00281	0.00281	CcSEcCtD
Gallamine Triethiodide—Confusional state—Thiotepa—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Thiotepa—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Thiotepa—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Epirubicin—urinary bladder cancer	0.00266	0.00266	CcSEcCtD
Gallamine Triethiodide—Anaemia—Gemcitabine—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Etoposide—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Doxorubicin—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Etoposide—urinary bladder cancer	0.0026	0.0026	CcSEcCtD
Gallamine Triethiodide—Anaemia—Fluorouracil—urinary bladder cancer	0.0026	0.0026	CcSEcCtD
Gallamine Triethiodide—Malaise—Gemcitabine—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Gemcitabine—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Fluorouracil—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Gallamine Triethiodide—Cough—Gemcitabine—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Thiotepa—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Doxorubicin—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Gallamine Triethiodide—Anaemia—Cisplatin—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Gemcitabine—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Gallamine Triethiodide—Chest pain—Gemcitabine—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Gallamine Triethiodide—Malaise—Cisplatin—urinary bladder cancer	0.0024	0.0024	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Gallamine Triethiodide—Chest pain—Fluorouracil—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Gallamine Triethiodide—Fatigue—Thiotepa—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Etoposide—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Cisplatin—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Gallamine Triethiodide—Pain—Thiotepa—urinary bladder cancer	0.00237	0.00237	CcSEcCtD
Gallamine Triethiodide—Confusional state—Fluorouracil—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Gemcitabine—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Gallamine Triethiodide—Anaemia—Etoposide—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Fluorouracil—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Gallamine Triethiodide—Urticaria—Thiotepa—urinary bladder cancer	0.0022	0.0022	CcSEcCtD
Gallamine Triethiodide—Malaise—Etoposide—urinary bladder cancer	0.0022	0.0022	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Thiotepa—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Thiotepa—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Etoposide—urinary bladder cancer	0.00218	0.00218	CcSEcCtD
Gallamine Triethiodide—Cough—Etoposide—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Cisplatin—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Cisplatin—urinary bladder cancer	0.00211	0.00211	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Gallamine Triethiodide—Chest pain—Etoposide—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Methotrexate—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Gallamine Triethiodide—Fatigue—Gemcitabine—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Gallamine Triethiodide—Confusional state—Etoposide—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Gallamine Triethiodide—Pain—Gemcitabine—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Methotrexate—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Gallamine Triethiodide—Asthenia—Thiotepa—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Gallamine Triethiodide—Pruritus—Thiotepa—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Gallamine Triethiodide—Pain—Fluorouracil—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Cisplatin—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Etoposide—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Epirubicin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Etoposide—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Thiotepa—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Epirubicin—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Gallamine Triethiodide—Pain—Cisplatin—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Gallamine Triethiodide—Urticaria—Fluorouracil—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Doxorubicin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Etoposide—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Gallamine Triethiodide—Vomiting—Thiotepa—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Gallamine Triethiodide—Rash—Thiotepa—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Thiotepa—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Gallamine Triethiodide—Headache—Thiotepa—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Cisplatin—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Fatigue—Etoposide—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Pain—Etoposide—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Methotrexate—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Methotrexate—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Gallamine Triethiodide—Asthenia—Gemcitabine—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Gallamine Triethiodide—Pruritus—Gemcitabine—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Gallamine Triethiodide—Nausea—Thiotepa—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Etoposide—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Gallamine Triethiodide—Pruritus—Fluorouracil—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Gallamine Triethiodide—Urticaria—Etoposide—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Epirubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Epirubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Etoposide—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Etoposide—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Epirubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Methotrexate—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Gallamine Triethiodide—Asthenia—Cisplatin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Cisplatin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Gallamine Triethiodide—Vomiting—Gemcitabine—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Gallamine Triethiodide—Rash—Gemcitabine—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Gemcitabine—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Epirubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Etoposide—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Gallamine Triethiodide—Headache—Gemcitabine—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Gallamine Triethiodide—Vomiting—Fluorouracil—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Doxorubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Gallamine Triethiodide—Rash—Fluorouracil—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Fluorouracil—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Gallamine Triethiodide—Headache—Fluorouracil—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Methotrexate—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Gallamine Triethiodide—Asthenia—Etoposide—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Gallamine Triethiodide—Pruritus—Etoposide—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Gallamine Triethiodide—Nausea—Gemcitabine—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Gallamine Triethiodide—Vomiting—Cisplatin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Gallamine Triethiodide—Rash—Cisplatin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Cisplatin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Etoposide—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Gallamine Triethiodide—Nausea—Fluorouracil—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Doxorubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Gallamine Triethiodide—Anaemia—Methotrexate—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Epirubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Gallamine Triethiodide—Malaise—Methotrexate—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Methotrexate—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Gallamine Triethiodide—Nausea—Cisplatin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Gallamine Triethiodide—Cough—Methotrexate—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Gallamine Triethiodide—Vomiting—Etoposide—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Gallamine Triethiodide—Anaemia—Epirubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Gallamine Triethiodide—Rash—Etoposide—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Etoposide—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Gallamine Triethiodide—Headache—Etoposide—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Gallamine Triethiodide—Chest pain—Methotrexate—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Methotrexate—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Malaise—Epirubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Epirubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Gallamine Triethiodide—Confusional state—Methotrexate—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Gallamine Triethiodide—Cough—Epirubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Gallamine Triethiodide—Nausea—Etoposide—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Gallamine Triethiodide—Anaemia—Doxorubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Epirubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Gallamine Triethiodide—Chest pain—Epirubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Methotrexate—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Gallamine Triethiodide—Malaise—Doxorubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Doxorubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Gallamine Triethiodide—Confusional state—Epirubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Gallamine Triethiodide—Cough—Doxorubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Epirubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Gallamine Triethiodide—Chest pain—Doxorubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Doxorubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Methotrexate—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Gallamine Triethiodide—Confusional state—Doxorubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Gallamine Triethiodide—Fatigue—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Gallamine Triethiodide—Pain—Methotrexate—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Doxorubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Epirubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000983	0.000983	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000963	0.000963	CcSEcCtD
Gallamine Triethiodide—Fatigue—Epirubicin—urinary bladder cancer	0.000962	0.000962	CcSEcCtD
Gallamine Triethiodide—Pain—Epirubicin—urinary bladder cancer	0.000954	0.000954	CcSEcCtD
Gallamine Triethiodide—Urticaria—Methotrexate—urinary bladder cancer	0.000947	0.000947	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Methotrexate—urinary bladder cancer	0.000943	0.000943	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000943	0.000943	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000941	0.000941	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000927	0.000927	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00092	0.00092	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000891	0.000891	CcSEcCtD
Gallamine Triethiodide—Fatigue—Doxorubicin—urinary bladder cancer	0.00089	0.00089	CcSEcCtD
Gallamine Triethiodide—Urticaria—Epirubicin—urinary bladder cancer	0.000887	0.000887	CcSEcCtD
Gallamine Triethiodide—Pain—Doxorubicin—urinary bladder cancer	0.000883	0.000883	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Epirubicin—urinary bladder cancer	0.000882	0.000882	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000882	0.000882	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000879	0.000879	CcSEcCtD
Gallamine Triethiodide—Asthenia—Methotrexate—urinary bladder cancer	0.000856	0.000856	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000851	0.000851	CcSEcCtD
Gallamine Triethiodide—Pruritus—Methotrexate—urinary bladder cancer	0.000844	0.000844	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000822	0.000822	CcSEcCtD
Gallamine Triethiodide—Urticaria—Doxorubicin—urinary bladder cancer	0.00082	0.00082	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000816	0.000816	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000816	0.000816	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000816	0.000816	CcSEcCtD
Gallamine Triethiodide—Asthenia—Epirubicin—urinary bladder cancer	0.000801	0.000801	CcSEcCtD
Gallamine Triethiodide—Pruritus—Epirubicin—urinary bladder cancer	0.00079	0.00079	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000764	0.000764	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000761	0.000761	CcSEcCtD
Gallamine Triethiodide—Vomiting—Methotrexate—urinary bladder cancer	0.000758	0.000758	CcSEcCtD
Gallamine Triethiodide—Rash—Methotrexate—urinary bladder cancer	0.000752	0.000752	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Methotrexate—urinary bladder cancer	0.000751	0.000751	CcSEcCtD
Gallamine Triethiodide—Headache—Methotrexate—urinary bladder cancer	0.000747	0.000747	CcSEcCtD
Gallamine Triethiodide—Asthenia—Doxorubicin—urinary bladder cancer	0.000741	0.000741	CcSEcCtD
Gallamine Triethiodide—Pruritus—Doxorubicin—urinary bladder cancer	0.000731	0.000731	CcSEcCtD
Gallamine Triethiodide—Vomiting—Epirubicin—urinary bladder cancer	0.00071	0.00071	CcSEcCtD
Gallamine Triethiodide—Nausea—Methotrexate—urinary bladder cancer	0.000708	0.000708	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000707	0.000707	CcSEcCtD
Gallamine Triethiodide—Rash—Epirubicin—urinary bladder cancer	0.000704	0.000704	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Epirubicin—urinary bladder cancer	0.000703	0.000703	CcSEcCtD
Gallamine Triethiodide—Headache—Epirubicin—urinary bladder cancer	0.000699	0.000699	CcSEcCtD
Gallamine Triethiodide—Nausea—Epirubicin—urinary bladder cancer	0.000663	0.000663	CcSEcCtD
Gallamine Triethiodide—Vomiting—Doxorubicin—urinary bladder cancer	0.000657	0.000657	CcSEcCtD
Gallamine Triethiodide—Rash—Doxorubicin—urinary bladder cancer	0.000651	0.000651	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Doxorubicin—urinary bladder cancer	0.00065	0.00065	CcSEcCtD
Gallamine Triethiodide—Headache—Doxorubicin—urinary bladder cancer	0.000647	0.000647	CcSEcCtD
Gallamine Triethiodide—Nausea—Doxorubicin—urinary bladder cancer	0.000613	0.000613	CcSEcCtD
